Sinopharm
1099.HK
#2268
Rank
A$10.30 B
Marketcap
$3.30
Share price
0.23%
Change (1 day)
-26.92%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: A$10.30 Billion

As of September 2024 Sinopharm has a market cap of A$10.30 Billion. This makes Sinopharm the world's 2268th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2024

End of year Market Cap

Year Market cap Change
2024A$10.30 B-14.1%
2023A$11.99 B2.74%
2022A$11.67 B25.06%
2021A$9.33 B-0.27%
2020A$9.36 B-39.38%
2019A$15.44 B-12.84%
2018A$17.71 B15.54%
2017A$15.33 B-3.06%
2016A$15.81 B3.77%
2015A$15.24 B27.68%
2014A$11.93 B44.51%
2013A$8.26 B13.96%
2012A$7.24 B28.88%
2011A$5.62 B-27.79%
2010A$7.79 B-13.39%
2009A$8.99 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Sinopharm was reported to be:

A$10.30 Billion
by Yahoo Finance info icon info icon
A$10.30 Billion
by CompaniesMarketCap info icon info icon